N-(5-(5-(3-(5-(5-(5-(4-(5-(5-(3-(5-(5-(5-(5-(3-(3-((3-aminopropyl)(methyl)amino)propylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylamino)-4-oxobutylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-ylamino)-3-oxopropylcarbamoyl)-1-methyl-1H-pyrrol-3-ylcarbamoyl)-1-methyl-1H-pyrrol-3-yl)-4-(bis(dimethylamino)methyleneamino)-1-methyl-1H-imidazole-2-carboxamide

ID: ALA4205776

Chembl Id: CHEMBL4205776

PubChem CID: 145975630

Max Phase: Preclinical

Molecular Formula: C96H122N34O16

Molecular Weight: 2008.25

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCCN)CCCNC(=O)CCNC(=O)c1cc(NC(=O)c2cc(NC(=O)c3cc(NC(=O)c4cc(NC(=O)CCNC(=O)c5cc(NC(=O)c6cc(NC(=O)CCCNC(=O)c7cc(NC(=O)c8cc(NC(=O)c9cc(NC(=O)CCNC(=O)c%10cc(NC(=O)c%11cc(NC(=O)c%12nc(N=C(N(C)C)N(C)C)cn%12C)cn%11C)cn%10C)cn9C)cn8C)cn7C)cn6C)cn5C)cn4C)cn3C)cn2C)cn1C

Standard InChI:  InChI=1S/C96H122N34O16/c1-116(2)96(117(3)4)115-78-55-130(17)83(114-78)95(146)113-66-43-77(129(16)54-66)94(145)109-62-39-70(122(9)50-62)87(138)102-30-24-82(134)104-57-34-72(124(11)45-57)89(140)110-63-40-74(126(13)51-63)91(142)107-59-36-67(119(6)47-59)84(135)99-26-18-21-80(132)103-56-33-71(123(10)44-56)88(139)106-60-38-69(121(8)48-60)86(137)101-29-23-81(133)105-58-35-73(125(12)46-58)90(141)111-64-41-76(128(15)52-64)93(144)112-65-42-75(127(14)53-65)92(143)108-61-37-68(120(7)49-61)85(136)100-28-22-79(131)98-27-20-32-118(5)31-19-25-97/h33-55H,18-32,97H2,1-17H3,(H,98,131)(H,99,135)(H,100,136)(H,101,137)(H,102,138)(H,103,132)(H,104,134)(H,105,133)(H,106,139)(H,107,142)(H,108,143)(H,109,145)(H,110,140)(H,111,141)(H,112,144)(H,113,146)

Standard InChI Key:  BYRJDEYUSLUNTP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4205776

    ---

Associated Targets(non-human)

Human papillomavirus (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 2008.25Molecular Weight (Monoisotopic): 2006.9778AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Castaneda CH, Scuderi MJ, Edwards TG, Harris GD, Dupureur CM, Koeller KJ, Fisher C, Bashkin JK..  (2016)  Improved Antiviral Activity of a Polyamide Against High-Risk Human Papillomavirus Via N-Terminal Guanidinium Substitution.,  (11): [PMID:27840672] [10.1039/C6MD00371K]

Source